We are thrilled to announce that Genomate Health will be participating in the prestigious American Society of Clinical Oncology (ASCO) 2023 Annual Meeting. With a rich history spanning over five decades, ASCO and its members have pioneered the field of modern clinical oncology, making significant progress in cancer treatment. This year's event promises to continue that legacy, working to leverage rapid advancements in science and technology for better patient outcomes.

Held in the bustling city of Chicago, Illinois, at the McCormick Place Convention Center from June 3 to June 5, 2023, ASCO 2023 will gather oncology professionals, patient advocates, industry representatives, and major media outlets from around the world. This premier scientific event offers an exceptional platform for Genomate Health to showcase its groundbreaking AI-driven technology and contribute to the future of personalized oncology.

As a leader in the field of AI-powered personalized cancer treatment, Genomate Health is excited to share our expertise and insights at this esteemed gathering. Our team will present the latest developments in our technology, demonstrate the impact it has on improving patient outcomes, and connect with other industry leaders to exchange ideas and forge collaborations.

We’ll be waiting you over at booth #22140 (E).

The ASCO 2023 Annual Meeting will cover a wide range of topics, including cutting-edge research, innovative treatment approaches, and the latest advancements in oncology. The event offers a unique opportunity for attendees to learn from and network with the brightest minds in the field, paving the way for future breakthroughs in cancer care.

Mark your calendars and join Genomate Health at ASCO 2023 (McCormick Place Convention Center, Chicago, Illinois). Register now to be part of the premier oncology event of the year and witness the future of cancer care in action. We can't wait to see you there!